Necon Kit
Product Images NDC 75907-085

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Necon (NDC 75907-085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structure diagram showing norethindrone on the left and ethinyl estradiol on the right, the active ingredients in the Necon oral kit by Dr. Reddy's Laboratories Inc.*

FDA Label Image

2 (Image 02)

A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Women-Years by Age, Smoking Status and Oral Contraceptive Use.' It shows mortality rates for age groups 15-24, 25-34, 35-44, and 45 and older, comparing ever-users and controls of oral contraceptives among smokers and non-smokers. The chart indicates higher mortality rates in smokers, especially ever-users aged 45 and older.*

FDA Label Image

3 (Image 03)

A warning text panel stating: Do not use Necon tablets if you smoke cigarettes and are over 35 years old. Smoking increases the risk of serious cardiovascular side effects including heart attack, blood clots, or stroke, which increase with age and cigarette quantity. The text is enclosed in a black rectangular border.*

FDA Label Image

4 (Image 04)

An example diagram of a 28-tablet blister card for Necon oral contraceptive kit containing norethindrone and ethinyl estradiol. The card is structured by weeks and days, with active light peach tablets and inactive white tablets, and includes usage instructions and reminders for monthly self breast exam and storage conditions. Labeler Dr. Reddy's Laboratories Inc. is mentioned.*

FDA Label Image

5 (Image 05)

An instructional diagram showing how to apply a day label strip to a Necon oral contraceptive kit blister pack. The image includes a hand peeling a day label for placement above the blister rows, with example pill color coding for active (light peach) and inactive (white) pills, and days of the week labeled across the top for tracking daily dosage.*

FDA Label Image

6 (Image 06)

A warning text panel for Necon tablets advising against use by individuals over 35 who smoke cigarettes, highlighting increased risks of serious cardiovascular side effects such as heart attack, blood clots, or stroke due to combination oral contraceptives.*

FDA Label Image

7 (Image 07)

Necon norethindrone and ethinyl estradiol oral contraceptive kit blister card with 28 tablets. The card features light peach active tablets and white inactive tablets arranged by day of the week in weekly rows. The right side includes dosing and storage instructions along with the tablet count and product name.*

FDA Label Image

8 (Image 08)

An instructional diagram for the Necon oral contraceptive kit showing a hand placing a day-of-week label strip (Mon-Sun) onto the pill pack. The pill pack is labeled with active light peach pills and an inactive white pill, demonstrating how to align the day labels with the pill schedule for correct daily dosing.*

FDA Label Image

9 (Image 09)

FDA Label Image

10 (Image 10)

Necon 0.5 mg/0.035 mg kit packaging label for oral norethindrone and ethinyl estradiol tablets, USP. The label states 3 blister cards of 28 tablets each, distributed by Dr. Reddy's Laboratories Inc. It includes active ingredient details, usage directions, and storage instructions, with barcodes and product identification numbers.*

FDA Label Image

Image Description (Image 11)

A forest plot chart illustrating the risk of breast cancer associated with combined oral contraceptive use from various studies. The horizontal axis shows effect estimates (odds ratio/relative risk) with confidence intervals for each study listed on the left, with points and error bars indicating the risk estimates and their confidence ranges compared to a baseline risk of 1.0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.